Doximity Announces Fiscal 2022 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Doximity Inc (DOCS) PT Raised to $90 at Needham & Company
November 10, 2021 6:57 AM ESTNeedham & Company analyst Scott Berg raised the price target on Doximity Inc (NYSE: DOCS) to $90.00 (from $62.00) while maintaining a Buy rating.
The analyst commented, "DOCS reported very good 2Q financial results including an 8% revenue beat and a 10% increase in FY22 revenue guidance. Overall... More
Doximity, Inc. (DOCS) Tops Q2 EPS by 9c; Guides Above
November 9, 2021 4:18 PM ESTDoximity, Inc. (NYSE: DOCS) reported Q2 EPS of $0.19, $0.09 better than the analyst estimate of $0.10. Revenue for the quarter came in at $79.4 million versus the consensus estimate of $73.5 million.
GUIDANCE:
Doximity, Inc. sees Q3 2022 revenue of $85.8-86.8 million, versus the consensus of... More
